About Autoimmunity BioSolutions
Autoimmunity BioSolutions is a private company based in Houston, Texas. It has reported $3,209,233 raised in one offering on Form D since November 2024. Its chief executive is Eugene Williams.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | Nov 22, 2024amended May 6, 2026 | $3,209,233fully sold | 15 | $213K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Autoimmunity BioSolutions's Form D filed May 6, 2026.
